Grossi PA; Gasperina DD; Barchiesi F; Biancofiore G; Carafiello G; De Gasperi A; Sganga G; Menichetti F; Montagna MT; Pea F; Venditti M; Viale P; Viscoli C; Nanni Costa A, Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients., «TRANSPLANTATION PROCEEDINGS», 2011, 43, pp. 2463 - 2471 [Scientific article]
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P, Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases., «TRANSPLANTATION PROCEEDINGS», 2011, 43, pp. 1119 - 1122 [Scientific article]
Pea F.; Cojutti P.; Sbrojavacca R.; Cadeo B.; Cristini F.; Bulfoni A.; Furlanut M., TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient, «THE ANNALS OF PHARMACOTHERAPY», 2011, 45, pp. e37 - 1022 [Scientific article]
Cataldo M.A.; Tacconelli E.; Pea F.; Petrosillo N., Vancomycin way of administration: Where is the evidence?, «CLINICAL INFECTIOUS DISEASES», 2011, 53, pp. 308 - 310 [Comment or similar]
Sartelli M; Viale P; Koike K; Pea F; Tumietto F; Van Goor H; Guercioni G; Nespoli A; Trana C; Catena F; Ansaloni L; Leppaniemi A; Biffl W; Moore FA; Poggetti R; Pinna AD; Moore EE., WSES consensus conference: Guidelines for first-line management of intra-abdominal infections., «WORLD JOURNAL OF EMERGENCY SURGERY», 2011, 6, pp. 2 - 31 [Scientific article]
Ippolito G.; Carosi G.; Moroni M.; Nicastri E.; Lauria F.N.; Mazzotta F.; Goglio A.; Pea F.; Blasi F.; Fortina G.; Rossano F., A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG, «INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES», 2010, 14, pp. S93 - S94 [Scientific article]
Viale P; Pea F, Capitolo 142 - Scelta dell'antibiotico nel malato critico, in: Medicina Critica, ITA, UTET Divisione Scienze Mediche, 2010, pp. 1221 - 1233 [Legal Commentary]
Arlotti M.; Grossi P.; Pea F.; Tomei G.; Vullo V.; De Rosa F.G.; Di Perri G.; Nicastri E.; Lauria F.N.; Carosi G.; Moroni M.; Ippolito G., Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses, «INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES», 2010, 14, pp. S79 - S92 [Scientific article]
Pea F; Furlanut M; Viale P, Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?, «THE JOURNAL OF TRAUMA, INJURY, INFECTION, AND CRITICAL CARE», 2010, 68, pp. 748 - 749 [Scientific article]
Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P., Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis., «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2010, 54, pp. 4605 - 4610 [Scientific article]
Pea, Federico; Viale, Pierluigi, Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?, «CRITICAL CARE», 2009, 214, pp. 1 - 13 [Scientific article]
Pea F; Viale P; Lugano M; Baccarani U; Pavan F; Tavio M; Adani GL; Della Rocca G; Furlanut M., Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2009, 63, pp. 167 - 169 [Scientific article]
Pea F; Furlanut M, Chapter 219 - Principles of pharmacodynamics and pharmacokinetics of drugs used in extracorporeal therapies, in: Critical Care Nephrology - 2nd edition, USA, Saunders Elsevier, 2009, pp. 1190 - 1194 [Legal Commentary]
Pea F; Viale P, Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?, «THE JOURNAL OF TRAUMA, INJURY, INFECTION, AND CRITICAL CARE», 2009, 66, pp. 348 - 1343 [Scientific article]
Pea F; Viale P, Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?, «THERAPEUTIC DRUG MONITORING», 2009, 21, pp. 135 - 136 [Comment or similar]
